Novel Blood-Based Biomarkers for HCC
- 3 January 2024
- journal article
- research article
- Published by Springer Nature in Current Hepatology Reports
- Vol. 23 (1) , 174-184
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Determinants of Serum Alpha-Fetoprotein Levels in Hepatitis C–Infected PatientsClinical Gastroenterology and Hepatology, 2012
- Surveillance for Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2012
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular CarcinomaGastroenterology, 2009
- Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in JapanHepatology Research, 2007
- Diagnosis of hepatocellular carcinomaHPB, 2005
- Randomized controlled trial of screening for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver CirrhosisHepatology, 2003
- About the possible origin and mechanism of circulating DNAClinica Chimica Acta, 2001
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001